New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2012
07:21 EDTCRIS, RHHBY
theflyonthewall.com: Curis target raised to $7.50 from $6 at Oppenheimer
Oppenheimer increased its target on Curis (CRIS) after the company and its partner, Roche (RHHBY), announced the approval of their drug Erivedge before its March PDUFA date. The drug is used to treat Advanced Basal Cell Carcinoma. Oppenheimer reiterates an Outperform rating on Curis. :theflyonthewall.com



News For CRIS;RHHBY From The Last 14 Days
Check below for free stories on CRIS;RHHBY the last two weeks.
There are 8 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
May 24, 2012
13:29 EDTRHHBY
theflyonthewall.com: Mylan launches generic version of Bonviva tablets in Italy and UK

Subscribe for More Information
:theflyonthewall.com
10:00 EDTRHHBY
theflyonthewall.com: Leerinks' life science tools and medical devices analysts hold a conference call
Life Science Tools Analyst Leonard and Medical Devices Analyst Newitter provide an update on OB/GYN surgical procedure trends, hereditary breast and ovarian cancer testnig trends and prenatal testing market update on an Analyst/Industry conference call. Relevant covered companies ALR, BDX, CPHD, GPRO, HOLX, MYGN, PKI, QGEN, RHHBY, SQNM and TECH may be included on the Analyst/Industry conference call to be held on May 24 at 2 pm. :theflyonthewall.com

May 21, 2012
07:38 EDTRHHBY
theflyonthewall.com: Sachs Associates to host a forum

Subscribe for More Information
:theflyonthewall.com
07:01 EDTRHHBY
theflyonthewall.com: Ventana licenses Gen-Probe IP for measuring ERG protein
Ventana Medical Systems, a member of the Roche, announced that it has co-exclusively sub-licensed certain patents and patent applications from Gen-Probe Incorporated for the worldwide in vitro diagnostic rights for measuring ERG protein expression through immunohistochemistry in prostate tissue. The license complements the existing Ventana worldwide co-exclusive sublicense under certain patents and patent applications for in situ hybridization rights for measuring ETS gene rearrangements, including ERG gene rearrangements in tissue. :theflyonthewall.com

May 18, 2012
06:32 EDTRHHBY
theflyonthewall.com: GlaxoSmithKline has upside following melanoma data, says Citigroup

Subscribe for More Information
:theflyonthewall.com

May 16, 2012
07:04 EDTRHHBY
theflyonthewall.com: Roche Alzheimer's drug to be tested on healthy people, NY Times says

Subscribe for More Information
:theflyonthewall.com

May 15, 2012
10:09 EDTRHHBY
theflyonthewall.com: Amylin climbs after report says seven companies involved in sales process

Subscribe for More Information
:theflyonthewall.com

May 14, 2012
07:35 EDTRHHBY
theflyonthewall.com: Deutsche Bank to host a conference
German, Swiss & Austrian Conference is being held in Frankfurt, Germany on May 14-16. :theflyonthewall.com